New Director

To: Companies Announcement Office

FOR IMMEDIATE RELEASE

18 December 2012

BIOQUELL PLC

Appointment of a non-executive director

In accordance with the Listing Rules of the Financial Services Authority, Bioquell PLC ("Bioquell") is pleased to announce that Mr. Christopher Mills will join the Board as a Non-Executive Director with effect from 18 December 2012.

Mr. Mills is the Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC ("NASCIT"), a director of Oryx International Growth Fund Limited ("Oryx") and is the Chief Investment Officer, and a member, of Harwood Capital LLP. NASCIT and Oryx own approximately 22.1% of Bioquell's issued ordinary share capital.

Mr. Mills is also a director of Sunlink Health Systems Inc, Bionostics Holdings Limited, Hampton Investment Properties, Second London American Trust PLC (in members' voluntary liquidation), Glass America, Inc, Progeny, Inc, Global Options, Celsis International Limited and MJ Gleeson PLC.

Commenting on the appointment, Nigel Keen, Chairman of Bioquell PLC said:

"We welcome Christopher Mills to our Board. He has a long record of successful investing in technology companies - and he is also the Chief Executive Officer of investment funds which together are our largest shareholder. We look forward to his contribution to our Board."

Enquiries:

Nigel Keen Chairman

Nick Adams Chief Executive

Bioquell PLC

01264 835 900